anmelden
OMX Nordic 40
2.685,57
PKT
-21,68
PKT
-0,80
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.06.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 27.06.19 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 21.06.19 | Nokia Outperform | Credit Suisse Group | |
| 21.06.19 | AstraZeneca buy | Deutsche Bank AG | |
| 20.06.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 18.06.19 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 18.06.19 | Novo Nordisk buy | UBS AG | |
| 18.06.19 | Ericsson (Telefon L.M.Ericsson) (B) Outperform | Credit Suisse Group | |
| 17.06.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 17.06.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 17.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.06.19 | Volvo (B) buy | Jefferies & Company Inc. | |
| 14.06.19 | Novo Nordisk buy | Deutsche Bank AG | |
| 14.06.19 | ABB (Asea Brown Boveri) Reduce | Oddo BHF | |
| 14.06.19 | A.P. Moeller - Maersk A-S (B) Hold | Deutsche Bank AG | |
| 13.06.19 | A.P. Moeller - Maersk A-S (B) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.06.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 12.06.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 11.06.19 | Nokia overweight | JP Morgan Chase & Co. | |
| 11.06.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 11.06.19 | Novo Nordisk buy | UBS AG | |
| 11.06.19 | Novo Nordisk Equal weight | Barclays Capital | |
| 11.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.06.19 | AstraZeneca buy | Deutsche Bank AG | |
| 05.06.19 | Novo Nordisk Outperform | Bernstein Research | |
| 04.06.19 | AstraZeneca buy | Deutsche Bank AG | |
| 04.06.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 04.06.19 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 03.06.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 03.06.19 | AstraZeneca Sell | UBS AG | |
| 31.05.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 30.05.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 29.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 28.05.19 | Novo Nordisk Reduce | HSBC | |
| 28.05.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 28.05.19 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 28.05.19 | A.P. Moeller - Maersk A-S (B) verkaufen | Barclays Capital | |
| 28.05.19 | Novo Nordisk Reduce | HSBC | |
| 24.05.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 24.05.19 | AstraZeneca Hold | Jefferies & Company Inc. |
